Back

Hypertriglyceridemia: combining diet, exercise training and drugs

16 November 2025 (09:15 - 09:30)
Organised by: Logo
Seminar Presentation Part of: Residual Risk after ACS/PCI: It’s not just a matter of LDL Acute Coronary Syndromes, Other Open Access ESC Heart & Stroke 2025 and EuroThrombosis 2025 Council on Stroke

3 More presentations in this session

Presentation thumbnail
Inflammation: from hsCRP to IL1, through IL6
Slides
Presentation thumbnail
Critical appraisal on anti-inflammatory drugs
Presentation thumbnail
The additive role of Lp(a) on top of LDL lowering
Slides

Access the full session

Session thumbnail
Residual Risk after ACS/PCI: It’s not just a matter of LDL

The Event

Event poster

ESC Heart & Stroke 2025 and EuroThrombosis 2025

16 November 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Welcome & introduction
29 August 2025
thumbnail
Congress Presentation
Insomnia due to hypertriglyceridemia can be treated by rosuvastatin/ezetimibe
13 April 2023
thumbnail
Congress Presentation
Changes in TRG/ApoA-1 ratio, TRG/HDL-C ratio and lipid serum profile after combination therapy with valsartan/amlodipine in prediabetic patients
7 April 2022
thumbnail
Congress Presentation
It’s not only about losing fat! Personalizing exercise in obese patients
26 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources